在低收入和中等收入国家实现药物遗传学方面迈出了一步:我们应该做什么?
Yudisia Ausi1,2, Melisa Intan Barliana2,3, Maarten J Postma3,4
1Doctor Program in Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, Indonesia.
Journal of multidisciplinary healthcare
|October 28, 2024
概括
药物遗传学通过将遗传变异与药物反应联系起来,加速了个性化医疗. 在低收入和中等收入国家实施面临诸如数据和资源有限等挑战,阻碍了进展.
科学领域:
- 药物遗传学和个性化医学
背景情况:
- 药物遗传学对于推进个性化医学和精准医疗保健至关重要.
- 由人类基因组项目推动的快速发展,已经在遗传变异和治疗结果之间建立了联系.
- 临床应用指南存在,但在全球范围内实施情况各不相同.
研究的目的:
- 全面讨论阻碍药物遗传学实施的挑战,特别是在低收入和中等收入国家 (LMICs).
- 探索药物遗传学引导的个性化医学的前景.
- 识别障碍,包括临床证据,技术,政策,监管和人力资源.
主要方法:
- 审查现有的药物遗传学文献和研究.
- 分析LMICs面临的挑战,包括数据稀缺.
- 讨论国际研究合作和证据生成.
主要成果:
- 在高收入和LMICs之间,药物遗传学的发展存在显著差异.
- 在LMICs的主要障碍包括缺乏临床证据,技术基础设施,支持政策和训练有素的人员.
- 在LMICs中,基因组和药物效应数据的稀缺性阻碍了进展.
结论:
- 在LMICs中扩大药物遗传学的发展需要基于证据的研究和国际合作.
- 解决数据,技术,政策和人力资源方面的挑战对于全球药物遗传学的进步至关重要.
- 克服这些障碍将促进药物遗传学引导的个性化医学的广泛采用.
相关概念视频
Analysis of Population Pharmacokinetic Data
235
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
235
Nonlinear Pharmacokinetics: Role of Transporters
35
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
35
Pharmacokinetic Models: Overview
600
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
600
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
60
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
60
Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
Nonlinear Pharmacokinetics: Overview
289
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
289


